Blue Jet Healthcare files draft papers for IPO

Blue Jet Healthcare, a specialty pharmaceutical and healthcare ingredient and intermediate company, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for an initial public offering (IPO). The proposed issue would be a complete offer-for-sale (OFS) of up to 21,683,178 equity shares by the promoter and selling shareholders.. The company operates under the "Blue Jet" brand name and has competencies and manufacturing capabilities in contrast media intermediates and high-intensity sweeteners, including saccharin and its salts as well as active pharmaceutical ingredients. Kotak Mahindra Capital Company, ICICI Securities, and J.P. Morgan India are the books running lead managers to the offer.